Evidence map›Paper›PMID 34011341›Full record

ArticleBMC medicine2021

Prevalence and predictors of vitamin D deficiency in young African children.

Reagan M Mogire, Alireza Morovat, John Muthii Muriuki, Alexander J Mentzer, Emily L Webb, Wandia Kimita, Francis M Ndungu, Alex W Macharia, Clare L Cutland, Sodiomon B Sirima and 12 more

Open access · goldAbstract read
In one paragraph

Article in BMC medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 10 institutions in 8 countries.

Reagan M MogireKenya Medical Research Institute (KEMRI) Centre for Geographic Medicine Coast, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya. reaganmoseti@gmail.com.ORCID 0000-0001-6454-1613
Alireza MorovatDepartment of Clinical Biochemistry, Oxford University Hospitals, Oxford, UK.
John Muthii MuriukiKenya Medical Research Institute (KEMRI) Centre for Geographic Medicine Coast, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Alexander J MentzerWellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Emily L WebbMedical Research Council (MRC) Tropical Epidemiology Group, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
Wandia KimitaKenya Medical Research Institute (KEMRI) Centre for Geographic Medicine Coast, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Francis M NdunguKenya Medical Research Institute (KEMRI) Centre for Geographic Medicine Coast, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Alex W MachariaKenya Medical Research Institute (KEMRI) Centre for Geographic Medicine Coast, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Clare L CutlandAfrican Leadership in Vaccinology Expertise (Alive), Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Sodiomon B SirimaGroupe de Recherche Action en Sante (GRAS), 06, 06 BP 10248, Ouagadougou, Burkina Faso.
Amidou DiarraGroupe de Recherche Action en Sante (GRAS), 06, 06 BP 10248, Ouagadougou, Burkina Faso.
Alfred B TionoGroupe de Recherche Action en Sante (GRAS), 06, 06 BP 10248, Ouagadougou, Burkina Faso.
Swaib A LuleMedical Research Council (MRC) Tropical Epidemiology Group, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
Shabir A MadhiSouth African Medical Research Council Vaccines and Infectious Diseases Analytical Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Manjinder S SandhuWellcome Sanger Institute, Hinxton, Cambridge, UK.
Andrew M PrenticeMRC Unit The Gambia at London School of Hygiene and Tropical Medicine, Banjul, The Gambia.
Philip BejonKenya Medical Research Institute (KEMRI) Centre for Geographic Medicine Coast, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
John M PettiforSouth African Medical Research Council/Wits Developmental Pathways for Health Research Unit, Department of Paediatrics, University of the Witwatersrand, Johannesburg, South Africa.
Alison M ElliottMedical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine Uganda Research Unit, Entebbe, Uganda.
Adebowale AdeyemoCentre for Research on Genomics and Global Health, National Human Genome Research Institute, National Institutes of Health, South Drive, MSC 5635, Bethesda, Maryland, 20891-5635, USA.
Thomas N WilliamsKenya Medical Research Institute (KEMRI) Centre for Geographic Medicine Coast, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Sarah H AtkinsonKenya Medical Research Institute (KEMRI) Centre for Geographic Medicine Coast, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya. satkinson@kemri-wellcome.org.
Kenya Medical Research Institute · KEGroupe de Recherche et d’Action sur le Foncier · BFLondon School of Hygiene & Tropical Medicine · GBCentre for Human Genetics · GBSouth African Medical Research Council · ZAMRC Unit the Gambia · GMNational Institutes of Health · USOxford University Hospitals NHS Trust · GBUniversity of the Witwatersrand · ZAWellcome Sanger Institute · GB

Funding

Genetic epidemiology of complex diseasesZIAHG200362 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI ROTIMI, CHARLES · 2009 to 2025
$54.7M
EPA EP-C-15-003Intramural NIH HHS ZIA HG200362Medical Research Council MC_PC_MR/R020183/1Medical Research Council MC_U123292701Medical Research Council MC_UU_00026/3Medical Research Council MC_UU_00027/5Medical Research Council MR/R010161/1Wellcome Trust 064693,079110, 095778Wellcome Trust 110255Wellcome Trust 202800Wellcome Trust 202800/Z/16/Z
6 · The paper itself

Abstract

backgroundChildren living in sub-Saharan Africa have a high burden of rickets and infectious diseases, conditions that are linked to vitamin D deficiency. However, data on the vitamin D status of young African children and its environmental and genetic predictors are limited. We aimed to examine the prevalence and predictors of vitamin D deficiency in young African children.

methodsWe measured 25-hydroxyvitamin D (25(OH)D) and typed the single nucleotide polymorphisms, rs4588 and rs7041, in the GC gene encoding the vitamin D binding protein (DBP) in 4509 children aged 0-8 years living in Kenya, Uganda, Burkina Faso, The Gambia and South Africa. We evaluated associations between vitamin D status and country, age, sex, season, anthropometric indices, inflammation, malaria and DBP haplotypes in regression analyses.

resultsMedian age was 23.9 months (interquartile range [IQR] 12.3, 35.9). Prevalence of vitamin D deficiency using 25(OH)D cut-offs of < 30 nmol/L and < 50 nmol/L was 0.6% (95% CI 0.4, 0.9) and 7.8% (95% CI 7.0, 8.5), respectively. Overall median 25(OH)D level was 77.6 nmol/L (IQR 63.6, 94.2). 25(OH)D levels were lower in South Africa, in older children, during winter or the long rains, and in those with afebrile malaria, and higher in children with inflammation. 25(OH)D levels did not vary by stunting, wasting or underweight in adjusted regression models. The distribution of Gc variants was Gc1f 83.3%, Gc1s 8.5% and Gc2 8.2% overall and varied by country. Individuals carrying the Gc2 variant had lower median 25(OH)D levels (72.4 nmol/L (IQR 59.4, 86.5) than those carrying the Gc1f (77.3 nmol/L (IQR 63.5, 92.8)) or Gc1s (78.9 nmol/L (IQR 63.8, 95.5)) variants.

conclusionsApproximately 0.6% and 7.8% of young African children were vitamin D deficient as defined by 25(OH)D levels < 30 nmol/L and < 50 nmol/L, respectively. Latitude, age, season, and prevalence of inflammation and malaria should be considered in strategies to assess and manage vitamin D deficiency in young children living in Africa.

Indexed as

Vitamin D DeficiencyAdultChildChild, PreschoolHaplotypesHumansPrevalenceSeasonsSouth AfricaVitamin DVitamin D-Binding ProteinYoung AdultVitamin DVitamin D-Binding Protein25-hydroxyvitamin DAfricaChildrenGC genotypeNutritionVitamin D binding proteinVitamin D deficiency

Identifiers

PMID34011341
PMCPMC8136043
OpenAlexW3162810712

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.